Abstract
Neurosurgical treatment for conditions such as epilepsy, traumatic brain injury, or brain tumor is often accompanied by perioperative psychiatric symptoms regardless of preexisting psychiatric conditions. These symptoms may be related to the underlying neurosurgical condition, the neurosurgical intervention itself (e.g., resection), or the medications used in the perioperative setting (e.g., anesthesia or corticosteroids). Comorbid neurological conditions may further complicate the management of the psychiatric presentations in this setting due to increased sensitivity to psychotropic medications or to the psychoactive effects of other agents. This chapter reviews the literature relevant to the perioperative psychiatric assessment and management in patients undergoing the most common neurosurgical procedures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Dewan MC, Rattani A, Fieggen G, Arraez MA, Servadei F, Boop FA, et al. Global neurosurgery: the current capacity and deficit in the provision of essential neurosurgical care. Executive summary of the global neurosurgery initiative at the program in global surgery and social change. J Neurosurg. 2018:1–10.
Faria MA. Neolithic trepanation decoded- a unifying hypothesis: has the mystery as to why primitive surgeons performed cranial surgery been solved? Surg Neurol Int. 2015;6:72.
Preul M. History of brain tumor surgery. Neurosurg Focus. 2005;18(4):1.
Menon DK, Schwab K, Wright DW, Maas AI. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil. 2010;91(11):1637–40.
Ganau M, Lavinio A, Prisco L. Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options. Minerva Anestesiol. 2018;84(5):632–40.
Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018:1–18.
Bratton SL, Chestnut RM, Ghajar J, Hammond FFM, Harris OA, Hartl R, et al. VII. Intracranial pressure monitoring technology. J Neurotrauma. 2007;24(supplement 1):S-45–54.
Feinberg M, Mai JC, Ecklund J. Neurosurgical management in traumatic brain injury. Semin Neurol. 2015;35(1):50–6.
Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the management of severe traumatic brain injury, 4th edition. Neurosurgery. 2017;80(1):6–15.
Bauer D, Tung ML, Tsao JW. Mechanisms of traumatic brain injury. Semin Neurol. 2015;35(1):e14–22.
McIntosh AS, Patton DA, Frechede B, Pierre PA, Ferry E, Barthels T. The biomechanics of concussion in unhelmeted football players in Australia: a case-control study. BMJ Open. 2014;4(5):e005078.
McAllister TW. Neurobiological consequences of traumatic brain injury. Dialogues Clin Neurosci. 2011;13(3):287–300.
Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet (London, England). 1974;2(7872):81–4.
McNett M. A review of the predictive ability of Glasgow coma scale scores in head-injured patients. J Neurosci Nurs. 2007;39(2):68–75.
Marshall LF, Marshall SB, Klauber MR, Van Berkum CM, Eisenberg H, Jane JA, et al. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma. 1992;9(Suppl 1):S287–92.
Raj R, Siironen J, Skrifvars MB, Hernesniemi J, Kivisaari R. Predicting outcome in traumatic brain injury: development of a novel computerized tomography classification system (Helsinki computerized tomography score). Neurosurgery. 2014;75(6):632–46. discussion 46-7.
Raj R, Mikkonen ED, Siironen J, Hernesniemi J, Lappalainen J, Skrifvars MB. Alcohol and mortality after moderate to severe traumatic brain injury: a meta-analysis of observational studies. J Neurosurg. 2016;124(6):1684–92.
Malec JF, Brown AW, Leibson CL, Flaada JT, Mandrekar JN, Diehl NN, et al. The mayo classification system for traumatic brain injury severity. J Neurotrauma. 2007;24(9):1417–24.
Deighton S, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, et al. Traumatic brain injury in individuals at clinical high risk for psychosis. Schizophr Res. 2016;174(1–3):77–81.
Castano Monsalve B, Bernabeu Guitart M, Lopez R, Bulbena Vilasar A, Ignacio QJ. Psychopathological evaluation of traumatic brain injury patients with the neuropsychiatric inventory. Rev Psiquiatr Salud Ment. 2012;5(3):160–6.
Fonda JR, Fredman L, Brogly SB, McGlinchey RE, Milberg WP, Gradus JL. Traumatic brain injury and attempted suicide among veterans of the wars in Iraq and Afghanistan. Am J Epidemiol. 2017;186(2):220–6.
Fisher LB, Pedrelli P, Iverson GL, Bergquist TF, Bombardier CH, Hammond FM, et al. Prevalence of suicidal behaviour following traumatic brain injury: longitudinal follow-up data from the NIDRR traumatic brain injury model systems. Brain Inj. 2016;30(11):1311–8.
Godbolt AK, Cancelliere C, Hincapie CA, Marras C, Boyle E, Kristman VL, et al. Systematic review of the risk of dementia and chronic cognitive impairment after mild traumatic brain injury: results of the international collaboration on mild traumatic brain injury prognosis. Arch Phys Med Rehabil. 2014;95(3 Suppl):S245–56.
Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM, Yaffe K. Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol. 2015;77(6):987–95.
Albrecht JS, Mullins DC, Smith GS, Rao V. Psychotropic medication use among medicare beneficiaries following traumatic brain injury. Am J Geriatr Psychiatry. 2017;25(4):415–24.
Childers MK, Holland D, Ryan MG, Rupright J. Obsessional disorders during recovery from severe head injury: report of four cases. Brain Inj. 1998;12(7):613–6.
Ciurli P, Formisano R, Bivona U, Cantagallo A, Angelelli P. Neuropsychiatric disorders in persons with severe traumatic brain injury: prevalence, phenomenology, and relationship with demographic, clinical, and functional features. J Head Trauma Rehabil. 2011;26(2):116–26.
Cotrena C, Branco LD, Zimmermann N, Cardoso CO, Grassi-Oliveira R, Fonseca RP. Impaired decision-making after traumatic brain injury: the Iowa gambling task. Brain Inj. 2014;28(8):1070–5.
Arbour C, Gelinas C. Behavioral and physiologic indicators of pain in nonverbal patients with a traumatic brain injury: an integrative review. Pain Manag Nurs. 2014;15(2):506–18.
Batty RA, Francis A, Thomas N, Hopwood M, Ponsford J, Rossell SL. A brief neurocognitive assessment of patients with psychosis following traumatic brain injury (PFTBI): use of the repeatable battery for the assessment of neuropsychological status (RBANS). Psychiatry Res. 2016;237:27–36.
Diaz AP, Schwarzbold ML, Thais ME, Cavallazzi GG, Schmoeller R, Nunes JC, et al. Personality changes and return to work after severe traumatic brain injury: a prospective study. Rev Bras Psiquiatr. 2014;36(3):213–9.
Grima N, Ponsford J, Rajaratnam SM, Mansfield D, Pase MP. Sleep disturbances in traumatic brain injury: a meta-analysis. J Clin Sleep Med: JCSM. 2016;12(3):419–28.
Grima NA, Ponsford JL, St Hilaire MA, Mansfield D, Rajaratnam SM. Circadian melatonin rhythm following traumatic brain injury. Neurorehabil Neural Repair. 2016;30(10):972–7.
Maneewong J, Maneeton B, Maneeton N, Vaniyapong T, Traisathit P, Sricharoen N, et al. Delirium after a traumatic brain injury: predictors and symptom patterns. Neuropsychiatr Dis Treat. 2017;13:459–65.
Kadyan V, Mysiw WJ, Bogner JA, Corrigan JD, Fugate LP, Clinchot DM. Gender differences in agitation after traumatic brain injury. Am J Phys Med Rehabil. 2004;83(10):747–52.
Mahmood S, Al-Thani H, El-Menyar A, Alani M, Al-Hassani A, Mathrdikkal S, et al. Tramadol in traumatic brain injury: should we continue to use it? J Anaesthesiol Clin Pharmacol. 2015;31(3):344–8.
Bombardier CH, Hoekstra T, Dikmen S, Fann JR. Depression trajectories during the first year after traumatic brain injury. J Neurotrauma. 2016;33(23):2115–24.
Bay E, Donders J. Risk factors for depressive symptoms after mild-to-moderate traumatic brain injury. Brain Inj. 2008;22(3):233–41.
Dunlop TW, Udvarhelyi GB, Stedem AF, O'Connor JM, Isaacs ML, Puig JG, et al. Comparison of patients with and without emotional/behavioral deterioration during the first year after traumatic brain injury. J Neuropsychiatry Clin Neurosci. 1991;3(2):150–6.
Chi YC, Wu HL, Chu CP, Huang MC, Lee PC, Chen YY. Traumatic brain injury and affective disorder: a nationwide cohort study in Taiwan, 2000-2010. J Affect Disord. 2016;191:56–61.
Albrecht JS, Kiptanui Z, Tsang Y, Khokhar B, Smith GS, Zuckerman IH, et al. Patterns of depression treatment in medicare beneficiaries with depression after traumatic brain injury. J Neurotrauma. 2015;32(16):1223–9.
Bryson CN, Cramer RJ, Schmidt AT. Traumatic brain injury and lifetime suicidality: applying the interpersonal-psychological theory perspective. Death Stud. 2017;41(7):399–405.
Scofield DE, Proctor SP, Kardouni JR, Hill OT, McKinnon CJ. Risk factors for mild traumatic brain injury and subsequent post-traumatic stress disorder and mental health disorders among United States Army soldiers. J Neurotrauma. 2017;34(23):3249–55.
Feinstein A, Hershkop S, Ouchterlony D, Jardine A, McCullagh S. Posttraumatic amnesia and recall of a traumatic event following traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2002;14(1):25–30.
Mellman TA, David D, Bustamante V, Fins AI, Esposito K. Predictors of post-traumatic stress disorder following severe injury. Depress Anxiety. 2001;14(4):226–31.
Bailie JM, Kennedy JE, French LM, Marshall K, Prokhorenko O, Asmussen S, et al. Profile analysis of the neurobehavioral and psychiatric symptoms following combat-related mild traumatic brain injury: identification of subtypes. J Head Trauma Rehabil. 2016;31(1):2–12.
Albicini MS, Lee J, McKinlay A. Ongoing daytime behavioural problems in university students following childhood mild traumatic brain injury. Int J Rehabil Res. 2016;39(1):77–83.
James ML, Olson DM, Graffagnino C. A pilot study of cerebral and haemodynamic physiological changes during sedation with dexmedetomidine or propofol in patients with acute brain injury. Anaesth Intensive Care. 2012;40(6):949–57.
Levy M, Berson A, Cook T, Bollegala N, Seto E, Tursanski S, et al. Treatment of agitation following traumatic brain injury: a review of the literature. NeuroRehabilitation. 2005;20(4):279–306.
Luaute J, Plantier D, Wiart L, Tell L. Care management of the agitation or aggressiveness crisis in patients with TBI. Systematic review of the literature and practice recommendations. Ann Phys Rehabil Med. 2016;59(1):58–67.
Krieger D, Hansen K, McDermott C, Matthews R, Mitchell R, Bollegala N, et al. Loxapine versus olanzapine in the treatment of delirium following traumatic brain injury. NeuroRehabilitation. 2003;18(3):205–8.
Noe E, Ferri J, Trenor C, Chirivella J. Efficacy of ziprasidone in controlling agitation during post-traumatic amnesia. Behav Neurol. 2007;18(1):7–11.
Kim E, Bijlani M. A pilot study of quetiapine treatment of aggression due to traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2006;18(4):547–9.
Phelps TI, Bondi CO, Mattiola VV, Kline AE. Relative to typical antipsychotic drugs, Aripiprazole is a safer alternative for alleviating behavioral disturbances after experimental brain trauma. Neurorehabil Neural Repair. 2017;31(1):25–33.
Folweiler KA, Bondi CO, Ogunsanya EA, LaPorte MJ, Leary JB, Radabaugh HL, et al. Combining the antipsychotic drug haloperidol and environmental enrichment after traumatic brain injury is a double-edged sword. J Neurotrauma. 2017;34(2):451–8.
Hoffman AN, Cheng JP, Zafonte RD, Kline AE. Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits. Life Sci. 2008;83(17–18):602–7.
Kline AE, Hoffman AN, Cheng JP, Zafonte RD, Massucci JL. Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury. Neurosci Lett. 2008;448(3):263–7.
Meythaler JM, Brunner RC, Johnson A, Novack TA. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil. 2002;17(4):300–13.
Chew E, Zafonte RD. Pharmacological management of neurobehavioral disorders following traumatic brain injury--a state-of-the-art review. J Rehabil Res Dev. 2009;46(6):851–79.
Leone H, Polsonetti BW. Amantadine for traumatic brain injury: does it improve cognition and reduce agitation? J Clin Pharm Ther. 2005;30(2):101–4.
Gramish JA, Kopp BJ, Patanwala AE. Effect of amantadine on agitation in critically ill patients with traumatic brain injury. Clin Neuropharmacol. 2017;40(5):212–6.
Grima NA, Rajaratnam SMW, Mansfield D, Sletten TL, Spitz G, Ponsford JL. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial. BMC Med. 2018;16(1):8.
Cantor JB, Ashman T, Bushnik T, Cai X, Farrell-Carnahan L, Gumber S, et al. Systematic review of interventions for fatigue after traumatic brain injury: a NIDRR traumatic brain injury model systems study. J Head Trauma Rehabil. 2014;29(6):490–7.
Leeds PR, Yu F, Wang Z, Chiu CT, Zhang Y, Leng Y, et al. A new avenue for lithium: intervention in traumatic brain injury. ACS Chem Neurosci. 2014;5(6):422–33.
Jorge RE, Acion L, Burin DI, Robinson RG. Sertraline for preventing mood disorders following traumatic brain injury: a randomized clinical trial. JAMA Psychiat. 2016;73(10):1041–7.
Fann JR, Uomoto JM, Katon WJ. Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics. 2001;42(1):48–54.
Failla MD, Juengst SB, Graham KM, Arenth PM, Wagner AK. Effects of depression and antidepressant use on cognitive deficits and functional cognition following severe traumatic brain injury. J Head Trauma Rehabil. 2016;31(6):E62–73.
Horsfield SA, Rosse RB, Tomasino V, Schwartz BL, Mastropaolo J, Deutsch SI. Fluoxetine’s effects on cognitive performance in patients with traumatic brain injury. Int J Psychiatry Med. 2002;32(4):337–44.
Khokhar B, Simoni-Wastila L, Albrecht JS. Risk of stroke among older medicare antidepressant users with traumatic brain injury. J Head Trauma Rehabil. 2017;32(1):E42–E9.
Lanctot KL, Rapoport MJ, Chan F, Rajaram RD, Strauss J, Sicard T, et al. Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury. Brain Inj. 2010;24(7–8):959–69.
Adamson BC, Ensari I, Motl RW. Effect of exercise on depressive symptoms in adults with neurologic disorders: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2015;96(7):1329–38.
Bogdanova Y, Yee MK, Ho VT, Cicerone KD. Computerized cognitive rehabilitation of attention and executive function in acquired brain injury: a systematic review. J Head Trauma Rehabil. 2016;31(6):419–33.
Bedard M, Felteau M, Marshall S, Dubois S, Gibbons C, Klein R, et al. Mindfulness-based cognitive therapy: benefits in reducing depression following a traumatic brain injury. Adv Mind Body Med. 2012;26(1):14–20.
Gertler P, Tate RL, Cameron ID. Non-pharmacological interventions for depression in adults and children with traumatic brain injury. Cochrane Database Syst Rev. 2015;12:CD009871.
Ahmed F, Bechtold K, Smith G, Roy D, Everett A, Rao V. Program of enhanced psychiatric services for patients with brain injury and neuropsychiatric disturbances: a proposed model of care. J Neuropsychiatry Clin Neurosci. 2016;28(2):147–52.
Zack MM, Kobau R. National and state estimates of the numbers of adults and children with active epilepsy - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66(31):821–5.
Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314–9.
Del Felice A, Beghi E, Boero G, La Neve A, Bogliun G, De Palo A, et al. Early versus late remission in a cohort of patients with newly diagnosed epilepsy. Epilepsia. 2010;51(1):37–42.
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51(6):1069–77.
Hamid H, Blackmon K, Cong X, Dziura J, Atlas LY, Vickrey BG, et al. Mood, anxiety, and incomplete seizure control affect quality of life after epilepsy surgery. Neurology. 2014;82(10):887–94.
National Association of Epilepsy Centers. Data of Participating Epilepsy Centers. http://www.naec -epilepsy.org/. 2012. Accessed 24 Apr.
Engel J Jr, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307(9):922–30.
West S, Nolan SJ, Cotton J, Gandhi S, Weston J, Sudan A, et al. Surgery for epilepsy. Cochrane Database Syst Rev. 2015;(7):Cd010541.
Schmidt D, Baumgartner C, Loscher W. The chance of cure following surgery for drug-resistant temporal lobe epilepsy. What do we know and do we need to revise our expectations? Epilepsy Res. 2004;60(2–3):187–201.
de Tisi J, Bell GS, Peacock JL, McEvoy AW, Harkness WF, Sander JW, et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet (London, England). 2011;378(9800):1388–95.
Engel J Jr. What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg lecture. Neurology. 2016;87(23):2483–9.
Berg AT, Langfitt J, Shinnar S, Vickrey BG, Sperling MR, Walczak T, et al. How long does it take for partial epilepsy to become intractable? Neurology. 2003;60(2):186–90.
Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. 2015;313(3):285–93.
Kaiboriboon K, Malkhachroum AM, Zrik A, Daif A, Schiltz NM, Labiner DM, et al. Epilepsy surgery in the United States: analysis of data from the National Association of epilepsy centers. Epilepsy Res. 2015;116:105–9.
Sawant N, Ravat S, Muzumdar D, Shah U. Is psychiatric assessment essential for better epilepsy surgery outcomes? Int J Surg (London, England). 2016;36(Pt B):460–5.
Cossu M, Fuschillo D, Cardinale F, Castana L, Francione S, Nobili L, et al. Stereo-EEG-guided radio-frequency thermocoagulations of epileptogenic grey-matter nodular heterotopy. J Neurol Neurosurg Psychiatry. 2014;85(6):611–7.
Dimova P, de Palma L, Job-Chapron AS, Minotti L, Hoffmann D, Kahane P. Radiofrequency thermocoagulation of the seizure-onset zone during stereoelectroencephalography. Epilepsia. 2017;58(3):381–92.
Wicks RT, Jermakowicz WJ, Jagid JR, Couture DE, Willie JT, Laxton AW, et al. Laser interstitial thermal therapy for mesial temporal lobe epilepsy. Neurosurgery. 2016;79(Suppl 1):S83–s91.
Jermakowicz WJ, Kanner AM, Sur S, Bermudez C, D'Haese PF, Kolcun JPG, et al. Laser thermal ablation for mesiotemporal epilepsy: analysis of ablation volumes and trajectories. Epilepsia. 2017;58(5):801–10.
Chan AY, Rolston JD, Rao VR, Chang EF. Effect of neurostimulation on cognition and mood in refractory epilepsy. Epilepsia Open. 2018;3(1):18–29.
Hauser WA. The natural history of drug resistant epilepsy: epidemiologic considerations. Epilepsy Res Suppl. 1992;5:25–8.
Engel J Jr. Surgery for seizures. N Engl J Med. 1996;334(10):647–52.
Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Epilepsia. 2003;44(6):741–51.
Holmes GL, Dorothee Kasteleijn-Nolst Trenite GA, Schachter SC. Behavioral aspects of epilepsy principles and practice. New York: Demos Medical Publishing; 2007.
Pre-surgical evaluation for epilepsy surgery - European standards. European federation of neurological societies task force. Eur J Neurol. 2000;7(1):119–22.
Dodrill BPH B, Rausch R, Chelune G, Oxbury S. Surgical treatment of epilepsies. In: Engel Jr J, editor. Use of neuropsychological tests for assessing prognosis following surgery for epilepsy. 2nd ed. New York: Raven Press; 1993. p. 263e271.
Jones-Gotman M. Localization of lesions by neuropsychological testing. Epilepsia. 1991;32(Suppl 5):S41–52.
Baxendale S, Thompson P, Harkness W, Duncan J. Predicting memory decline following epilepsy surgery: a multivariate approach. Epilepsia. 2006;47(11):1887–94.
Alpherts WC, Vermeulen J, van Rijen PC, da Silva FH, van Veelen CW. Verbal memory decline after temporal epilepsy surgery?: a 6-year multiple assessments follow-up study. Neurology. 2006;67(4):626–31.
Pintor L, Bailles E, Fernandez-Egea E, Sanchez-Gistau V, Torres X, Carreno M, et al. Psychiatric disorders in temporal lobe epilepsy patients over the first year after surgical treatment. Seizure. 2007;16(3):218–25.
Tellez-Zenteno JF, Wiebe S. Chapter 1 – Prevalence of psychiatric disorders in patients with epilepsy: what we think we know and what we know. In: Kanner AM, Schachter SC, editors. Psychiatric controversies in epilepsy. San Diego: Academic Press; 2008. p. 1–18.
Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110(4):207–20.
Devinsky O. Psychiatric comorbidity in patients with epilepsy: implications for diagnosis and treatment. Epilepsy Behav: E&B. 2003;4(Suppl 4):S2–10.
Filho GM, Rosa VP, Lin K, Caboclo LO, Sakamoto AC, Yacubian EM. Psychiatric comorbidity in epilepsy: a study comparing patients with mesial temporal sclerosis and juvenile myoclonic epilepsy. Epilepsy Behav: E&B. 2008;13(1):196–201.
Filho GM, Mazetto L, da Silva JM, Caboclo LO, Yacubian EM. Psychiatric comorbidity in patients with two prototypes of focal versus generalized epilepsy syndromes. Seizure. 2011;20(5):383–6.
Manchanda R. Psychiatric disorders in epilepsy: clinical aspects. Epilepsy Behav. 2002;3(1):39–45.
Swinkels WA, van Emde BW, Kuyk J, van Dyck R, Spinhoven P. Interictal depression, anxiety, personality traits, and psychological dissociation in patients with temporal lobe epilepsy (TLE) and extra-TLE. Epilepsia. 2006;47(12):2092–103.
Anhoury S, Brown RJ, Krishnamoorthy ES, Trimble MR. Psychiatric outcome after temporal lobectomy: a predictive study. Epilepsia. 2000;41(12):1608–15.
Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry. 2003;54(3):388–98.
Kanner AM. Chapter 16 – Should a psychiatric evaluation be included in every pre-surgical work-up? In: Kanner AM, Schachter SC, editors. Psychiatric controversies in epilepsy. San Diego: Academic Press; 2008. p. 239–54.
Koch-Stoecker SC, Bien CG, Schulz R, May TW. Psychiatric lifetime diagnoses are associated with a reduced chance of seizure freedom after temporal lobe surgery. Epilepsia. 2017;58(6):983–93.
Altalib HH, Berg AT, Cong X, Vickrey BG, Sperling MR, Shinnar S, et al. Presurgical depression and anxiety are not associated with worse epilepsy surgery outcome five years postoperatively. Epilepsy Behav: E&B. 2018;83:7–12.
Koch-Stoecker S. Personality disorders as predictors of severe postsurgical psychiatric complications in epilepsy patients undergoing temporal lobe resections. Epilepsy Behav: E&B. 2002;3(6):526–31.
Kanner AM, Byrne R, Chicharro A, Wuu J, Frey M. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology. 2009;72(9):793–9.
Koch-Stoecker S, Schmitz B, Kanner AM. Treatment of postsurgical psychiatric complications. Epilepsia. 2013;54(Suppl 1):46–52.
Greenberg DB. Epilepsy. In: Fogel BS, Greenberg DB, editors. Psychiatric Care of the Medical Patient. 3rd ed. New York: Oxford University Press; 2015.
Engel J Jr. The current place of epilepsy surgery. Curr Opin Neurol. 2018;31(2):192–7.
Cleary RA, Baxendale SA, Thompson PJ, Foong J. Predicting and preventing psychopathology following temporal lobe epilepsy surgery. Epilepsy Behav: E&B. 2013;26(3):322–34.
Macrodimitris S, Sherman EM, Forde S, Tellez-Zenteno JF, Metcalfe A, Hernandez-Ronquillo L, et al. Psychiatric outcomes of epilepsy surgery: a systematic review. Epilepsia. 2011;52(5):880–90.
Busch RM, Dulay MF, Kim KH, Chapin JS, Jehi L, Kalman CC, et al. Pre-surgical mood predicts memory decline after anterior temporal lobe resection for epilepsy. Arch Clin Neuropsychol. 2011;26(8):739–45.
Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they? Neurology. 2002;58(8 Suppl 5):S27–39.
Hamid H, Liu H, Cong X, Devinsky O, Berg AT, Vickrey BG, et al. Long-term association between seizure outcome and depression after resective epilepsy surgery. Neurology. 2011;77(22):1972–6.
Reutens DC, Savard G, Andermann F, Dubeau F, Olivier A. Results of surgical treatment in temporal lobe epilepsy with chronic psychosis. Brain. 1997;120(Pt 11):1929–36.
Devinsky O, Barr WB, Vickrey BG, Berg AT, Bazil CW, Pacia SV, et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology. 2005;65(11):1744–9.
Hermann BP, Wyler AR. Depression, locus of control, and the effects of epilepsy surgery. Epilepsia. 1989;30(3):332–8.
Reuber M, Andersen B, Elger CE, Helmstaedter C. Depression and anxiety before and after temporal lobe epilepsy surgery. Seizure. 2004;13(2):129–35.
Barry JJ, Ettinger AB, Friel P, Gilliam FG, Harden CL, Hermann B, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav: E&B. 2008;13(Suppl 1):S1–29.
Hovorka J, Herman E, Nemcova II. Treatment of Interictal depression with citalopram in patients with epilepsy. Epilepsy Behav: E&B. 2000;1(6):444–7.
Kuhn KU, Quednow BB, Thiel M, Falkai P, Maier W, Elger CE. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav: E&B. 2003;4(6):674–9.
Specchio LM, Iudice A, Specchio N, La Neve A, Spinelli A, Galli R, et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol. 2004;27(3):133–6.
Ribot R, Ouyang B, Kanner AM. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: is it worth investigating? Epilepsy Behav: E&B. 2017;70(Pt A):5–9.
Maguire MJ, Weston J, Singh J, Marson AG. Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. 2014;(12):Cd010682.
Kerr MP, Mensah S, Besag F, de Toffol B, Ettinger A, Kanemoto K, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia. 2011;52(11):2133–8.
Swinkels JA, de Jonghe F. Safety of antidepressants. Int Clin Psychopharmacol. 1995;9(Suppl 4):19–25.
Munchau A, Langosch JM, Gerschlager W, Rothwell JC, Orth M, Trimble MR. Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. J Neurol Neurosurg Psychiatry. 2005;76(4):527–33.
Kaufman KR, Saucedo C, Schaeffer J, Levesque M, Scannell T, Glouberman M. Electroconvulsive therapy (ECT) for intractable depression following epilepsy neurosurgery. Seizure. 1996;5(4):307–12.
Aksoy-Poyraz C, Ozdemir A, Ozmen M, Arikan K, Ozkara C. Electroconvulsive therapy for bipolar depressive and mixed episode with high suicide risk after epilepsy surgery. Epilepsy Behav: E&B. 2008;13(4):707–9.
Beyenburg S, Mitchell AJ, Schmidt D, Elger CE, Reuber M. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav: E&B. 2005;7(2):161–71.
Manchanda R, Schaefer B, McLachlan RS, Blume WT, Wiebe S, Girvin JP, et al. Psychiatric disorders in candidates for surgery for epilepsy. J Neurol Neurosurg Psychiatry. 1996;61(1):82–9.
Ring HA, Moriarty J, Trimble MR. A prospective study of the early postsurgical psychiatric associations of epilepsy surgery. J Neurol Neurosurg Psychiatry. 1998;64(5):601–4.
Wrench J, Wilson SJ, Bladin PF. Mood disturbance before and after seizure surgery: a comparison of temporal and extratemporal resections. Epilepsia. 2004;45(5):534–43.
Mula M, Monaco F. Antiepileptic drugs and psychopathology of epilepsy: an update. Epileptic Disord. 2009;11(1):1–9.
Harnod T, Wang YC, Kao CH. Association between benzodiazepine use and epilepsy occurrence: a Nationwide population-based case-control study. Medicine (Baltimore). 2015;94(37):e1571.
Monaco F, Cavanna A, Magli E, Barbagli D, Collimedaglia L, Cantello R, et al. Obsessionality, obsessive-compulsive disorder, and temporal lobe epilepsy. Epilepsy Behav: E&B. 2005;7(3):491–6.
Kulaksizoglu IB, Bebek N, Baykan B, Imer M, Gurses C, Sencer S, et al. Obsessive-compulsive disorder after epilepsy surgery. Epilepsy Behav: E&B. 2004;5(1):113–8.
Roth RM, Jobst BC, Thadani VM, Gilbert KL, Roberts DW. New-onset obsessive-compulsive disorder following neurosurgery for medication-refractory seizure disorder. Epilepsy Behav: E&B. 2009;14(4):677–80.
Schmitz B. Depression and mania in patients with epilepsy. Epilepsia. 2005;46(Suppl 4):45–9.
Kanemoto K, Kawasaki J, Kawai I. Postictal psychosis: a comparison with acute interictal and chronic psychoses. Epilepsia. 1996;37(6):551–6.
Carran MA, Kohler CG, O'Connor MJ, Bilker WB, Sperling MR. Mania following temporal lobectomy. Neurology. 2003;61(6):770–4.
Engel J, Pedley TA, Aicardi J, editors. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers. p. 2169–78.
Blumer D, Wakhlu S, Davies K, Hermann B. Psychiatric outcome of temporal lobectomy for epilepsy: incidence and treatment of psychiatric complications. Epilepsia. 1998;39(5):478–86.
Maixner D, Sagher O, Bess J, Edwards J. Catatonia following surgery for temporal lobe epilepsy successfully treated with electroconvulsive therapy. Epilepsy Behav: E&B. 2010;19(3):528–32.
Iranzo-Tatay C, Rubio-Granero T, Gutierrez A, Garces M, Conde R, Gomez-Ibanez A, et al. Psychiatric symptoms after temporal epilepsy surgery. A one-year follow-up study. Epilepsy Behav: E&B. 2017;70(Pt A):154–60.
D'Alessio L, Scevola L, Fernandez Lima M, Oddo S, Solis P, Seoane E, et al. Psychiatric outcome of epilepsy surgery in patients with psychosis and temporal lobe drug-resistant epilepsy: a prospective case series. Epilepsy Behav: E&B. 2014;37:165–70.
Whitworth AB, Fleischhacker WW. Adverse effects of antipsychotic drugs. Int Clin Psychopharmacol. 1995;9(Suppl 5):21–7.
McConnell H, Duncan D. Chapter 10. Treatment of psychiatric, comorbidity in epilepsy. In: McConnell H, Snyder P, editors. Psychiatric comorbidity in epilepsy. Washington, DC: Press. DAP; 1998. p. 245–361.
Toth P, Frankenburg FR. Clozapine and seizures: a review. Can J Psychiatr Rev Can Psychiatr. 1994;39(4):236–8.
Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62(4):345–54.
Pompili M, Girardi P, Tatarelli G, Angeletti G, Tatarelli R. Suicide after surgical treatment in patients with epilepsy: a meta-analytic investigation. Psychol Rep. 2006;98(2):323–38.
Hamid H, Devinsky O, Vickrey BG, Berg AT, Bazil CW, Langfitt JT, et al. Suicide outcomes after resective epilepsy surgery. Epilepsy Behav: E&B. 2011;20(3):462–4.
Wilson SJ, Bladin PF, Saling MM. The burden of normality: a framework for rehabilitation after epilepsy surgery. Epilepsia. 2007;48(Suppl 9):13–6.
Ramos-Perdigues S, Bailles E, Mane A, Carreno M, Donaire A, Rumia J, et al. A prospective study contrasting the psychiatric outcome in drug-resistant epilepsy between patients who underwent surgery and a control group. Epilepsia. 2016;57(10):1680–90.
Helmstaedter C. Cognitive outcomes of different surgical approaches in temporal lobe epilepsy. Epileptic Disord. 2013;15(3):221–39.
Vermeulen L, van Loon J, Theys T, Goffin J, Porke K, Van Laere K, et al. Outcome after epilepsy surgery at the university hospitals Leuven 1998-2012. Acta Neurol Belg. 2016;116(3):271–8.
Lutz MT, Clusmann H, Elger CE, Schramm J, Helmstaedter C. Neuropsychological outcome after selective amygdalohippocampectomy with transsylvian versus transcortical approach: a randomized prospective clinical trial of surgery for temporal lobe epilepsy. Epilepsia. 2004;45(7):809–16.
Ives-Deliperi VL, Butler JT. Naming outcomes of anterior temporal lobectomy in epilepsy patients: a systematic review of the literature. Epilepsy Behav: E&B. 2012;24(2):194–8.
Lee TM, Yip JT, Jones-Gotman M. Memory deficits after resection from left or right anterior temporal lobe in humans: a meta-analytic review. Epilepsia. 2002;43(3):283–91.
Tellez-Zenteno JF, Dhar R, Hernandez-Ronquillo L, Wiebe S. Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain. 2007;130(Pt 2):334–45.
Sherman EM, Wiebe S, Fay-McClymont TB, Tellez-Zenteno J, Metcalfe A, Hernandez-Ronquillo L, et al. Neuropsychological outcomes after epilepsy surgery: systematic review and pooled estimates. Epilepsia. 2011;52(5):857–69.
Vaz SA. Nonverbal memory functioning following right anterior temporal lobectomy: a meta-analytic review. Seizure. 2004;13(7):446–52.
Helmstaedter C, Kurthen M, Lux S, Reuber M, Elger CE. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol. 2003;54(4):425–32.
Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311–8.
Elsharkawy AE, May T, Thorbecke R, Koch-Stoecker S, Villagran A, Urak L, et al. Long-term outcome and determinants of quality of life after temporal lobe epilepsy surgery in adults. Epilepsy Res. 2009;86(2–3):191–9.
Wilson SJ, Wrench JM, McIntosh AM, Bladin PF, Berkovic SF. Profiles of psychosocial outcome after epilepsy surgery: the role of personality. Epilepsia. 2010;51(7):1133–8.
Hamiwka L, Macrodimitris S, Tellez-Zenteno JF, Metcalfe A, Wiebe S, Kwon CS, et al. Social outcomes after temporal or extratemporal epilepsy surgery: a systematic review. Epilepsia. 2011;52(5):870–9.
Hermann BP, Trenerry MR, Colligan RC. Learned helplessness, attributional style, and depression in epilepsy. Bozeman epilepsy surgery consortium. Epilepsia. 1996;37(7):680–6.
Wilson S, Bladin P, Saling M. The “burden of normality”: concepts of adjustment after surgery for seizures. J Neurol Neurosurg Psychiatry. 2001;70(5):649–56.
Naesstrom M, Blomstedt P, Bodlund O. A systematic review of psychiatric indications for deep brain stimulation, with focus on major depressive and obsessive-compulsive disorder. Nord J Psychiatry. 2016;70(7):483–91.
Youngerman BE, Chan AK, Mikell CB, McKhann GM, Sheth SA. A decade of emerging indications: deep brain stimulation in the United States. J Neurosurg. 2016;125(2):461–71.
Kisely S, Li A, Warren N, Siskind D. A systematic review and meta-analysis of deep brain stimulation for depression. Depress Anxiety. 2018;35(5):468–80.
Johnson MD, McIntyre CC. Quantifying the neural elements activated and inhibited by globus pallidus deep brain stimulation. J Neurophysiol. 2008;100(5):2549–63.
Barrett K. Psychiatric neurosurgery in the 21st century: overview and the growth of deep brain stimulation. BJPsych Bull. 2017;41(5):281–6.
Gross RE, McDougal ME. Technological advances in the surgical treatment of movement disorders. Curr Neurol Neurosci Rep. 2013;13(8):371.
Savica R, Grossardt BR, Rocca WA, Bower JH. Parkinson disease with and without dementia: a prevalence study and future projections. Mov Disord. 2018;33(4):537–43.
Kulick CV, Montgomery KM, Nirenberg MJ. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson’s disease psychosis. Parkinsonism Relat Disord. 2018;pii:S1353–8020(18):30153–6.
Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2008;23(2):183–9. quiz 313.
Larsen JP, Dalen I, Pedersen KF, Tysnes OB. The natural history of depressive symptoms in patients with incident Parkinson’s disease: a prospective cohort study. J Neurol. 2017;264(12):2401–8.
Wang JW, Zhang YQ, Zhang XH, Wang YP, Li JP, Li YJ. Cognitive and psychiatric effects of STN versus GPi deep brain stimulation in Parkinson’s disease: a meta-analysis of randomized controlled trials. PLoS One. 2016;11(6):e0156721.
Broen MPG, Leentjens AFG, Hinkle JT, Moonen AJH, Kuijf ML, Fischer NM, et al. Clinical markers of anxiety subtypes in Parkinson disease. J Geriatr Psychiatry Neurol. 2018;31(2):55–62.
Merims D, Balas M, Peretz C, Shabtai H, Giladi N. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. Clin Neuropharmacol. 2006;29(6):331–7.
Thomas AA, Friedman JH. Current use of clozapine in Parkinson disease and related disorders. Clin Neuropharmacol. 2010;33(1):14–6.
Majlath Z, Obal I, Vecsei L. Treatment possibilities for psychosis in Parkinson’s disease with an emphasis on the newly approved drug: Pimavanserin. CNS Neurol Disord Drug Targets. 2017;16(3):234–43.
Andre M, Rezai AR, Kopell BH, Gross RE, Sharan AD, Benabid AL. Deep brain stimulation for Parkinson’s disease: surgical technique and perioperative management. Mov Disord. 2006;21(14):S247–S58.
Fidel BCJ, Richard S, Joseph J. Diagnosis and treatment of complications related to deep brain stimulation hardware. Mov Disord. 2011;26(8):1398–406.
Günther D, Jan H, Galit KF, Cynthia K, Lozano AM, Lyons KE, et al. Deep brain stimulation: postoperative issues. Mov Disord. 2006;21(14):S219–S37.
Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro-Oncology. 2012;14(Suppl 5):v1–v49.
Keschner M, Bender MB, Strauss I. Mental symptoms associated with brain tumor: a study of 530 verified cases. JAMA. 1938;110(10):714–8.
Kaplan HISB. Psychiatric aspects of brain tumors: a review. Mental disorders due to general medical condition. In: Kaplan HI, Sadock BJ, editors. Synopsis of psychiatry. 8th ed. Philadelphia: Lippincot Williams & Wilkins; 1998. p. 350–64.
Gupta RK, Kumar R. Benign brain tumours and psychiatric morbidity: a 5-years retrospective data analysis. Aust N Z J Psychiatry. 2004;38(5):316–9.
Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr. Depression in patients with high-grade glioma: results of the Glioma outcomes project. Neurosurgery. 2004;54(2):358–66. discussion 66-7.
Madhusoodanan S, Ting MB, Farah T, Ugur U. Psychiatric aspects of brain tumors: a review. World J Psychiatry. 2015;5(3):273–85.
Boettger S, Jenewein J, Breitbart W. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: a comparison of efficacy, safety, and side effects. Palliat Support Care. 2015;13(4):1079–85.
Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry. 1996;153(2):231–7.
Gathinji M, McGirt MJ, Attenello FJ, Chaichana KL, Than K, Olivi A, et al. Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surg Neurol. 2009;71(3):299–303. discussion.
Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998;16(7):2522–7.
Caudill JS, Brown PD, Cerhan JH, Rummans TA. Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience. Am J Clin Oncol. 2011;34(4):385–7.
Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neuro-Oncol. 2012;107(1):165–74.
Roth AJ, Jaeger A. Psychiatric issues in cancer patients. In: The American Cancer Society’s principles of oncology: John Wiley & Sons, Inc; 2018. p. 379–92.
Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database Syst Rev. 2013;(5):Cd006932.
Robinson S, Kissane DW, Brooker J, Burney S. A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. J Pain Symptom Manag. 2015;49(3):595–610.
Mehta RD, Roth AJ. Psychiatric considerations in the oncology setting. CA Cancer J Clin. 2015;65(4):299–314.
Conklin HM, Reddick WE, Ashford J, Ogg S, Howard SC, Morris EB, et al. Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors. J Clin Oncol. 2010;28(29):4465–72.
Castellino SM, Tooze JA, Flowers L, Hill DF, McMullen KP, Shaw EG, et al. Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study. Pediatr Blood Cancer. 2012;59(3):540–7.
Rapp SR, Case LD, Peiffer A, Naughton MM, Chan MD, Stieber VW, et al. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. J Clin Oncol. 2015;33(15):1653–9.
Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-Oncology. 2013;15(10):1429–37.
Price TRGK, Lovell MR. Neuropsychiatric aspects of brain tumors. In: Yudofsky SC, Hales RE, editors. The American Psychiatric Publishing textbook of neuropsychiatry and behavioral neurosciences. 5th ed. Arlington: American Psychiatric Publishing; 2007. p. 735–64.
Rossetti AO, Stupp R. Epilepsy in brain tumor patients. Curr Opin Neurol. 2010;23(6):603–9.
Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the quality standards Subcommittee of the American Academy of neurology. Neurology. 2000;54(10):1886–93.
Halma E, de Louw AJ, Klinkenberg S, Aldenkamp AP, DM IJ, Majoie M. Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review. Seizure. 2014;23(9):685–91.
Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361–7.
Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord. 1983;5(4):319–32.
Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol. 2004;92(5):500–5.
Dubovsky AN, Arvikar S, Stern TA, Axelrod L. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosom. 2012;53(2):103–15.
LA Davis JM, Merk BS, Janicak PG. Treatment of steroid psychoses. Psychiatr Ann. 1992;22:487–91.
Hurria A, Somlo G, Ahles T. Renaming “chemobrain”. Cancer Investig. 2007;25(6):373–7.
Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care. 2007;5(3):273–80.
Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011;38(3):431–8.
Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015;65(2):123–38.
Huang T, Mueller S, Rutkowski MJ, Han SJ, Bloch O, Barani IJ, et al. Multidisciplinary care of patients with brain tumors. Surg Oncol Clin N Am. 2013;22(2):161–78.
Clinical radiation oncology [electronic resource]. Bogart JA, Gunderson LL, Tepper JE, editors. Philadelphia: Elsevier; 2016.
Hess CB, Chen AM. Measuring psychosocial functioning in the radiation oncology clinic: a systematic review. Psychooncology. 2014;23(8):841–54.
Holmes EG, Holmes JA, Park EM. Psychiatric care of the radiation oncology patient. Psychosomatics. 2017;58(5):457–65.
Greenberg DB. Brain tumor. In: Fogel BS, Greenberg DB, editors. Psychiatric care of the medical patient. 3rd ed. New York, USA: Oxford University Press; 2015.
Kim S, Akpati HC, Li JG, Liu CR, Amdur RJ, Palta JR. An immobilization system for claustrophobic patients in head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2004;59(5):1531–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Munjal, S., Zimbrean, P.C. (2019). Perioperative Psychiatric Aspects in Neurosurgery. In: Zimbrean, P., Oldham, M., Lee, H. (eds) Perioperative Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-99774-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-99774-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99773-5
Online ISBN: 978-3-319-99774-2
eBook Packages: MedicineMedicine (R0)